Advancing Safe Medications for Moms and Babies Act of 2026
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The Advancing Safe Medications for Moms and Babies Act of 2026 directs the FDA to harmonize its clinical trial regulations to facilitate the inclusion of pregnant women in drug research studies. The bill requires the FDA to finalize updated regulations within 180 days and establishes a public education campaign to inform patients, healthcare providers, and families about clinical trials and registries involving pregnant and lactating women. Additionally, it directs the National Institutes of Health to establish a research prioritization process and fund studies on existing and new drugs used by pregnant and lactating women.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.